Insider · CIK 0001608022
FAVUS ELLIOT
Reports to the SEC for 1 company · NEW YORK, NY
Transactions
33
Companies
1
Filings
2
CIK
0001608022
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$45K |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$46K |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$8,460 |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$8,355 |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$7,350 |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$8,490 |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$9,165 |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$148K |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP.S Sale | −$1.7M |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-05-21 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-02-24 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$117K |
| 2021-02-24 | AVXLANAVEX LIFE SCIENCES CORP.M Exercise/Conversion | +$328K |
| 2021-02-24 | AVXLANAVEX LIFE SCIENCES CORP.S Sale | −$1.84M |
| 2021-02-24 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-02-24 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2020-12-30 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2020-01-06 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2018-10-01 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2016-09-22 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2016-06-30 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2016-04-27 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2016-03-31 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2015-12-31 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2015-12-31 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option/Right to BuyA Award | — |
| 2015-09-30 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option (Right to Buy)A Award | — |
| 2015-04-02 | AVXLANAVEX LIFE SCIENCES CORP. · Stock Option/Right to BuyA Award | — |
Recent filings
- 4FAVUS ELLIOT0001731122-21-000941SEC(opens sec.gov)
- 4FAVUS ELLIOT0001731122-21-000308SEC(opens sec.gov)
Companies
Address
51 W 52ND STREET 7TH FLOOR
NEW YORK, NY, 10019-6163